Cargando…

Using creative co-design to develop a decision support tool for people with malignant pleural effusion

BACKGROUND: Malignant pleural effusion (MPE) is a common, serious problem predominantly seen in metastatic lung and breast cancer and malignant pleural mesothelioma. Recurrence of malignant pleural effusion is common, and symptoms significantly impair people’s daily lives. Numerous treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Grindell, Cheryl, Tod, Angela, Bec, Remi, Wolstenholme, Daniel, Bhatnagar, Rahul, Sivakumar, Parthipan, Morley, Anna, Holme, Jayne, Lyons, Judith, Ahmed, Maryam, Jackson, Susan, Wallace, Deirdre, Noorzad, Farinaz, Kamalanathan, Meera, Ahmed, Liju, Evison, Mathew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404910/
https://www.ncbi.nlm.nih.gov/pubmed/32758243
http://dx.doi.org/10.1186/s12911-020-01200-3
_version_ 1783567194016186368
author Grindell, Cheryl
Tod, Angela
Bec, Remi
Wolstenholme, Daniel
Bhatnagar, Rahul
Sivakumar, Parthipan
Morley, Anna
Holme, Jayne
Lyons, Judith
Ahmed, Maryam
Jackson, Susan
Wallace, Deirdre
Noorzad, Farinaz
Kamalanathan, Meera
Ahmed, Liju
Evison, Mathew
author_facet Grindell, Cheryl
Tod, Angela
Bec, Remi
Wolstenholme, Daniel
Bhatnagar, Rahul
Sivakumar, Parthipan
Morley, Anna
Holme, Jayne
Lyons, Judith
Ahmed, Maryam
Jackson, Susan
Wallace, Deirdre
Noorzad, Farinaz
Kamalanathan, Meera
Ahmed, Liju
Evison, Mathew
author_sort Grindell, Cheryl
collection PubMed
description BACKGROUND: Malignant pleural effusion (MPE) is a common, serious problem predominantly seen in metastatic lung and breast cancer and malignant pleural mesothelioma. Recurrence of malignant pleural effusion is common, and symptoms significantly impair people’s daily lives. Numerous treatment options exist, yet choosing the most suitable depends on many factors and making decisions can be challenging in pressured, time-sensitive clinical environments. Clinicians identified a need to develop a decision support tool. This paper reports the process of co-producing an initial prototype tool. METHODS: Creative co-design methods were used. Three pleural teams from three disparate clinical sites in the UK were involved. To overcome the geographical distance between sites and the ill-health of service users, novel distributed methods of creative co-design were used. Local workshops were designed and structured, including video clips of activities. These were run on each site with clinicians, patients and carers. A joint national workshop was then conducted with representatives from all stakeholder groups to consider the findings and outputs from local meetings. The design team worked with participants to develop outputs, including patient timelines and personas. These were used as the basis to develop and test prototype ideas. RESULTS: Key messages from the workshops informed prototype development. These messages were as follows. Understanding and managing the pleural effusion was the priority for patients, not their overall cancer journey. Preferred methods for receiving information were varied but visual and graphic approaches were favoured. The main influences on people’s decisions about their MPE treatment were personal aspects of their lives, for example, how active they are, what support they have at home. The findings informed the development of a first prototype/service visualisation (a video representing a web-based support tool) to help people identify personal priorities and to guide shared treatment decisions. CONCLUSION: The creative design methods and distributed model used in this project overcame many of the barriers to traditional co-production methods such as power, language and time. They allowed specialist pleural teams and service users to work together to create a patient-facing decision support tool owned by those who will use it and ready for implementation and evaluation.
format Online
Article
Text
id pubmed-7404910
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74049102020-08-07 Using creative co-design to develop a decision support tool for people with malignant pleural effusion Grindell, Cheryl Tod, Angela Bec, Remi Wolstenholme, Daniel Bhatnagar, Rahul Sivakumar, Parthipan Morley, Anna Holme, Jayne Lyons, Judith Ahmed, Maryam Jackson, Susan Wallace, Deirdre Noorzad, Farinaz Kamalanathan, Meera Ahmed, Liju Evison, Mathew BMC Med Inform Decis Mak Research Article BACKGROUND: Malignant pleural effusion (MPE) is a common, serious problem predominantly seen in metastatic lung and breast cancer and malignant pleural mesothelioma. Recurrence of malignant pleural effusion is common, and symptoms significantly impair people’s daily lives. Numerous treatment options exist, yet choosing the most suitable depends on many factors and making decisions can be challenging in pressured, time-sensitive clinical environments. Clinicians identified a need to develop a decision support tool. This paper reports the process of co-producing an initial prototype tool. METHODS: Creative co-design methods were used. Three pleural teams from three disparate clinical sites in the UK were involved. To overcome the geographical distance between sites and the ill-health of service users, novel distributed methods of creative co-design were used. Local workshops were designed and structured, including video clips of activities. These were run on each site with clinicians, patients and carers. A joint national workshop was then conducted with representatives from all stakeholder groups to consider the findings and outputs from local meetings. The design team worked with participants to develop outputs, including patient timelines and personas. These were used as the basis to develop and test prototype ideas. RESULTS: Key messages from the workshops informed prototype development. These messages were as follows. Understanding and managing the pleural effusion was the priority for patients, not their overall cancer journey. Preferred methods for receiving information were varied but visual and graphic approaches were favoured. The main influences on people’s decisions about their MPE treatment were personal aspects of their lives, for example, how active they are, what support they have at home. The findings informed the development of a first prototype/service visualisation (a video representing a web-based support tool) to help people identify personal priorities and to guide shared treatment decisions. CONCLUSION: The creative design methods and distributed model used in this project overcame many of the barriers to traditional co-production methods such as power, language and time. They allowed specialist pleural teams and service users to work together to create a patient-facing decision support tool owned by those who will use it and ready for implementation and evaluation. BioMed Central 2020-08-05 /pmc/articles/PMC7404910/ /pubmed/32758243 http://dx.doi.org/10.1186/s12911-020-01200-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Grindell, Cheryl
Tod, Angela
Bec, Remi
Wolstenholme, Daniel
Bhatnagar, Rahul
Sivakumar, Parthipan
Morley, Anna
Holme, Jayne
Lyons, Judith
Ahmed, Maryam
Jackson, Susan
Wallace, Deirdre
Noorzad, Farinaz
Kamalanathan, Meera
Ahmed, Liju
Evison, Mathew
Using creative co-design to develop a decision support tool for people with malignant pleural effusion
title Using creative co-design to develop a decision support tool for people with malignant pleural effusion
title_full Using creative co-design to develop a decision support tool for people with malignant pleural effusion
title_fullStr Using creative co-design to develop a decision support tool for people with malignant pleural effusion
title_full_unstemmed Using creative co-design to develop a decision support tool for people with malignant pleural effusion
title_short Using creative co-design to develop a decision support tool for people with malignant pleural effusion
title_sort using creative co-design to develop a decision support tool for people with malignant pleural effusion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404910/
https://www.ncbi.nlm.nih.gov/pubmed/32758243
http://dx.doi.org/10.1186/s12911-020-01200-3
work_keys_str_mv AT grindellcheryl usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT todangela usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT becremi usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT wolstenholmedaniel usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT bhatnagarrahul usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT sivakumarparthipan usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT morleyanna usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT holmejayne usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT lyonsjudith usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT ahmedmaryam usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT jacksonsusan usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT wallacedeirdre usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT noorzadfarinaz usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT kamalanathanmeera usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT ahmedliju usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion
AT evisonmathew usingcreativecodesigntodevelopadecisionsupporttoolforpeoplewithmalignantpleuraleffusion